Hired by a Yale professor to investigate the suspicious unavailability of a critical chemotherapy drug, Erin Pulaski discovers that its manufacturer is imposing a shortage to enable billions in windfall profits, a finding that is complicated by the brutal murder of a top employee. By the best-selling author of Knockout. 400,000 first printing.,
